Comprehensive Evaluation of Herbal Plants for Cancer Prevention

Year : 2025 | Volume : 12 | Issue : 02 | Page : 01 07
    By

    Ayush Pandita,

  • Yachika Sharma,

  1. Student, Department of Biotechnology, Kurukshetra University, Kurukshetra, Haryana, India
  2. Student, Department of Biotechnology, Kurukshetra University, Kurukshetra, Haryana, India

Abstract

Since cancer continues to be a major cause of morbidity and death globally, effective prevention measures are desperately needed. As the world’s cancer burden increases, interest in alternative cancer prevention methods, particularly the use of herbal medicine, is also increasing. With their rich history and diverse phytochemical composition, medicinal plants provide a great opportunity for the development of disease prevention strategies. This review explores the potential of various plants, including their bioactive compounds, mechanisms of action, and scientific evidence supporting their anti-inflammatory properties. The main findings suggest that many herbal plants have significant anti-inflammatory properties, which can be attributed to their ability to alter cellular processes associated with cancer healing, such as apoptosis, inflammation, and oxidative stress. Despite the benefits gained from clinical and therapeutic research, there remain issues with the formulation, bioavailability, and administration of herbal products. Future research should focus on resolving these issues, conducting rigorous clinical trials, and exploring the integration of herbals with cancer therapy. This review highlights the potential of herbals as important tools in cancer prevention and explores more ways to bring their health benefits to the public.

Keywords: Curcuma longa (turmeric), Withania somnifera (Ashwagandha), Herb- Drug Interactions, Withania somnifera (Ashwagandha), Herb-Drug Interactions.

[This article belongs to Research & Reviews: A Journal of Pharmacognosy ]

How to cite this article:
Ayush Pandita, Yachika Sharma. Comprehensive Evaluation of Herbal Plants for Cancer Prevention. Research & Reviews: A Journal of Pharmacognosy. 2025; 12(02):01-07.
How to cite this URL:
Ayush Pandita, Yachika Sharma. Comprehensive Evaluation of Herbal Plants for Cancer Prevention. Research & Reviews: A Journal of Pharmacognosy. 2025; 12(02):01-07. Available from: https://journals.stmjournals.com/rrjopc/article=2025/view=205248


References

  1. American Cancer Society, Cancer Prevention & Early Detection Facts & Figures, 2023-2024, https://www.cancer.org/research/cancer-facts-statistics/cancer-prevention-early-detection.html
  2. Park M, Kim H. Anti-cancer Mechanism of Docosahexaenoic Acid in Pancreatic Carcinogenesis: A Mini-review. J Cancer Prev. 2017 Mar;22(1):1-5. doi: 10.15430/JCP.2017.22.1.1.
  3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313. doi: 10.3322/caac.21609.
  4. Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. Medicinal plants in therapy. Bull World Health Organ. 1985;63(6):965-81.
  5. Kumar, S., Singh, A., & Sharma, S. (2019). Phytochemicals in cancer prevention: A review. Journal of Cancer Research and Therapeutics, 15(2), 247-255. doi: 10.4103/jcrt.JCRT_158_16
  6. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12. Erratum in: CA Cancer J Clin. 2021 Jul;71(4):359. doi: 10.3322/caac.21669.
  7. Cancer [Internet]. Who.int. World Health Organization: WHO; 2019 [cited 2025 Mar 26]. Available from: https://www.who.int/health-topics/cancer#tab=tab_1 ‌.
  8. García-Maceira T, García-Maceira FI, González-Reyes JA, Paz-Rojas E. Highly enhanced ELISA sensitivity using acetylated chitosan surfaces. BMC biotechnology. 2020 Dec;20:1-2.
  9. Kumar, A., et al. (2018). Alkaloids: An important class of phytochemicals in cancer therapy. Journal of Medicinal Plants Research, 12(1), 1-10. doi:10.5897/JMPR2017.6283
  10. Li, M., et al. (2016). Flavonoids: Potential anticancer agents. Phytotherapy Research, 30(5), 737-749. doi:10.1002/ptr.5582
  11. Srinivasan, K. (2005). Role of Spices Beyond Food Flavoring: Nutraceuticals with Multiple Health Effects. Food Reviews International, 21(2), 167–188. https://doi.org/10.1081/FRI-200051872
  12. Syed DN, Afaq F, Mukhtar H. Pomegranate derived products for cancer chemoprevention. Semin Cancer Biol. 2007 Oct;17(5):377-85. doi: 10.1016/j.semcancer.2007.05.004.
  13. Kaur T, Singh H, Mishra R, Manchanda S, Gupta M, Saini V, Sharma A, Kaur G. Withania somnifera as a potential anxiolytic and immunomodulatory agent in acute sleep deprived female Wistar rats. Mol Cell Biochem. 2017 Mar;427(1-2):91-101. doi: 10.1007/s11010-016-2900-1.
  14. Seeram, N. P., et al. (2006). Pomegranate juice and extract: A review of the health benefits. Journal of Nutritional Biochemistry, 17(5), 291-298. doi:10.1016/j.jnutbio.2005.12.002
  15. Sharma, R., et al. (2016). Withania somnifera: A review of its anticancer properties. Journal of Cancer Research and Therapeutics, 12(1), 1-6. doi:10.4103/0973-1482.155123
  16. Sinha, R., et al. (2019). Garlic and cancer prevention: A systematic review. Nutrition and Cancer, 71(1), 1-10. doi:10.1080/01635581.2018.1541234
  17. Zhang, L., et al. (2018). Green tea consumption and risk of cancer: A meta-analysis. European Journal of Clinical Nutrition, 72(1), 1-10. doi:10.1038/s41430-018-0220-0
  18. Jenča A, Mills DK, Ghasemi H, Saberian E, Jenča A, Karimi Forood AM, Petrášová A, Jenčová J, Jabbari Velisdeh Z, Zare-Zardini H, Ebrahimifar M. Herbal Therapies for Cancer Treatment: A Review of Phytotherapeutic Efficacy. Biologics. 2024;18:229-255 https://doi.org/10.2147/BTT.S484068
  19. Goyal S, Beniwal SK, Kumar HS, Kumar D, Das BC. Role of Curcumin in reducing toxicity and adverse effects in locally advanced and metastatic breast cancer patients. Annals of Oncology. 2019 Oct 1;30:vi126-7.
  20. Khan H, Ullah H, Martorell M, Valdes SE, Belwal T, Tejada S, Sureda A, Kamal MA. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects. InSeminars in cancer biology 2021 Feb 1 (Vol. 69, pp. 200-211). Academic Press https://doi.org/10.1016/j.semcancer.2019.07.023 .
  21. Shakeel F, Fang F, Kidwell KM, Marcath LA, Hertz DL. Comparison of eight screening tools to detect interactions between herbal supplements and oncology agents. Journal of Oncology Pharmacy Practice. 2020;26(8):1843-1849. doi:10.1177/1078155220905009
  22. Wong, L. Y. E., Wong, C. K., Leung, P. C., & Lam, W. K. C. (2010). The efficacy of herbal therapy on quality of life in patients with breast cancer: self-control clinical trial. Patient Preference and Adherence, 4, 223–229. https://doi.org/10.2147/ppa.s10961 .
  23. Liu J, Hou W, Gönen M, Seluzicki C, Li SQ, Mao JJ. Symptom burden and willingness to participate: implications for herbal clinical trials in lung cancer. Ann Palliat Med. 2021 Feb;10(2):1895-1903. doi: 10.21037/apm-20-865.
  24. Alsanad, S.M., Howard, R.L. & Williamson, E.M. An assessment of the impact of herb-drug combinations used by cancer patients. BMC Complement Altern Med 16, 393 (2016). https://doi.org/10.1186/s12906-016-1372-x
  25. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003 Jan-Feb;23(1A):363-98.
Regular Issue Subscription Review Article
Volume 12
Issue 02
Received 25/02/2025
Accepted 25/03/2025
Published 29/03/2025
Publication Time 32 Days
317


My IP

PlumX Metrics